HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regine Muehlfriedel Selected Research

Color Vision Defects (Color Blindness)

11/2022Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Regine Muehlfriedel Research Topics

Disease

1Color Vision Defects (Color Blindness)
11/2022
1Edema (Dropsy)
10/2009

Drug/Important Bio-Agent (IBA)

2Retinaldehyde (Retinal)IBA
11/2022 - 10/2009